Novartis and GSK announce €3.2M collaboration to support scientific research into genetic diversity in Africa 19 Jan 2021 News
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine 06 Oct 2020 News
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 14 Apr 2020 News
New UK government chief scientist will come from the pharma industry New UK government chief scientist will come from the pharma industry President of R&D at GlaxoSmithKline, Patrick Vallance, will replace Mark Walport in April 2018 09 Nov 2017 News
Prosensa agrees £412M deal with GSK for commercialisation of muscular dystrophy treatment 14 Oct 2009 News
New £37M drug development campus to pioneer open innovation A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners. 14 Oct 2009 News